✦ LIBER ✦

Animal Models of Movement Disorders || Utility of 6-Hydroxydopamine Lesioned Rats in the Preclinical Screening of Novel Treatments for Parkinson Disease

✍ Scribed by Cenci, M. Angela

Book ID: 120937283
Publisher: Elsevier
Year: 2005
Weight: 331 KB
Category: Article
ISBN: 0120883821
DOI: 10.1016/B978-012088382-0/50016-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Flibanserin attenuatesl-DOPA-sensitized

Flibanserin attenuatesl-DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson’s disease

✍ Manfred Gerlach; Jürgen Beck; Peter Riederer; Maarten van den Buuse 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 219 KB

Motor behavioural changes after intracer

Motor behavioural changes after intracerebroventricular injection of 6-hydroxydopamine in the rat: an animal model of Parkinson's disease

✍ Manuel Rodrı́guez Dı́az; Patricio Abdala; Pedro Barroso-Chinea; José Obeso; Tomá 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 602 KB

Neuroprotective effect of the methanolic

Neuroprotective effect of the methanolic extract of Hibiscus asper leaves in 6-hydroxydopamine-lesioned rat model of Parkinson's disease

✍ Lucian Hritcu; Harquin Simplice Foyet; Marius Stefan; Marius Mihasan; Acha Emman 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 534 KB

Nonmotor symptoms in Parkinson's disease

Nonmotor symptoms in Parkinson's disease: Investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model

✍ Igor Branchi; Ivana D'Andrea; Monica Armida; Tommaso Cassano; Antonella Pèzzola; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB 👁 1 views

## Abstract To investigate the psychiatric symptoms accompanying the early phases of Parkinson's disease (PD), we injected adult rats with 10.5 μg 6‐hydroxydopamine (6‐OHDA) bilaterally into the dorsal striatum. The resulting neurodegeneration led, 12 weeks after injection, to a mild (36%) reductio

Characterization of Enhanced Behavioral

Characterization of Enhanced Behavioral Responses tol-DOPA Following Repeated Administration in the 6-Hydroxydopamine-Lesioned Rat Model of Parkinson's Disease

✍ Brian Henry; Alan R. Crossman; Jonathan M. Brotchie 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Knockdown of interleukin-1 receptor 1 is

Knockdown of interleukin-1 receptor 1 is not neuroprotective in the 6-hydroxydopamine striatal lesion rat model of Parkinson's disease

✍ Walsh, Sinéad; Gavin, Aisling; Wyatt, Séan; O'Connor, Catriona; Keeshan, Karen; 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 824 KB